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level of regulation of mitochondrial function, which is particularly important in neurons, is their active
transport along microtubules. Recent evidence suggests that the mitochondrial fusion/ﬁssion machinery as
well as the molecular motors responsible for their movement constitute powerful regulatory control points
that directly impact metabolism and regulation of cell death. This is true for not only apoptosis, but also for
excitotoxicity where calcium overload is a major component of the cell death process. In this review, we will
describe the molecular mechanisms regulating fusion and ﬁssion and how this impinges on cell survival in
the context of acute neuronal injury.
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As the powerhouse of the cell, mitochondria play a crucial role in
energy metabolism. In addition, recent research has highlighted other
aspects of mitochondrial function that play key roles in cell survival
and death [1,2]. Mitochondria are highly dynamic organelles that
undergo constant cycles of fusion and ﬁssion. This dynamic behavior
of mitochondria is required for proper mitochondrial function and
distribution and plays an important role in cell death. Mitochondrial
dynamics also impinge on a second important mitochondrial function,
calcium buffering, which regulates signal transduction pathways,
metabolism, and cell death. An additional level of regulation, which is
particularly important in neurons, is the active transport of mito-
chondria along microtubules. These processes regulate not only
normal function and distribution of mitochondria but also several
types of cell death such as apoptosis and excitotoxicity. Below, we
describe the molecular mechanism regulating fusion and ﬁssion and
their impact on cell survival in the context of acute neuronal injury.
2. Mechanisms that regulate mitochondrial fusion and ﬁssion
In healthy cells, mitochondrial fusion and ﬁssion are ongoing
processes that are essential for development and survival (reviewed
in [1,2]). For example, ﬁssion is required during cell division to
properly distribute mitochondria to daughter cells [3,4] while fusion
allows rapid mixing of mitochondrial content in order to buffer
localized substrate deﬁcits or complement damaged mitochondrial
DNA [5,6]. In neurons, mitochondrial ﬁssion is essential for mito-
chondrial transport to their potential docking sites in axons and.
ll rights reserved.dendrites and is tightly associated with development of spines and
synapses [7,8]. In addition, mitochondrial dynamics play a role in the
proper recruitment of mitochondria to strategic locations such as
areas of high metabolic demand. This is especially important in
neurons because of their peculiar morphological characteristics. At
the molecular level, three key GTPases mediate mitochondrial fusion
and ﬁssion events in mammalian cells (Fig. 1). These include
mitofusins (MFN1/2), optic atrophy 1 (OPA1), and dynamin-related
protein 1 (DRP1), which are brieﬂy described below (for a recent
review, see [9]).
2.1. Mitofusins
MFN1 and MFN2 are integral outer mitochondrial membrane
(OMM) proteins that regulate OMM fusion. Although MFN1 and
MFN2 have overlapping functions, they are also believed to have
distinct roles [10–12]. MFN1 is mainly involved in the docking of two
juxtaposed mitochondria while MFN2 could potentially act as a
regulatory GTPase [11–14]. Speciﬁc roles for MFN2 include modula-
tion of metabolism by affecting the electron transport chain [15,16]
and tethering of endoplasmic reticulum to mitochondria [17]. Of note,
GTP hydrolysis by MFN2 is not required for fusion as a hydrolysis-
deﬁcient mutant of MFN2 (MFN2RasG12V) can still induce mitochon-
drial fusion [13,14]. In addition, point mutations in MFN2 are
associatedwith Charcot–Marie–Tooth neuropathy type II, a peripheral
nerve neuropathy causing progressive muscle weakness and muscu-
lar atrophy [18].
2.2. OPA1
OPA1, an intermembrane space protein associated with the inner
mitochondrial membrane (IMM), regulates IMM fusion as well as
Fig. 1. Regulation of mitochondrial ﬁssion/fusion. (A) Mitofusins (Mfn1 and Mfn2) are
located on the outer mitochondrial membranes (OMM) and regulate fusion of the
OMM. Mfns interact on apposing mitochondria to mediate their tethering (arrow 1).
This results in OMM fusion (arrow 2). OPA1, an intermembrane space GTPase which is
found in association with the innermitochondrial membrane (IMM), mediates fusion of
IMM (arrow 3). (B) The key regulator of mitochondrial ﬁssion is dynamin-related
protein 1 (DRP1). DRP1 is a cytosolic GTPase which is recruited to the mitochondria at
the site of scission (arrow 1). DRP1 forms a ring-like structure on the mitochondria
surface. The energy from the GTP hydrolysis drives constriction of the membranes
(arrow 2).
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as several proteases that can cleave its transmembrane domain,
suggesting a complex mode of regulation. [22–24]. Recent studies
have also demonstrated that both its full-length (L-OPA1) and cleaved
(S-OPA1) forms are required for IMM fusion [23,24]. The functional
importance of OPA1 was highlighted by the discovery that mutations
in OPA1 lead to a severe neuropathy, autosomal dominant optic
atrophy (ADOA), characterized by a progressive degeneration of optic
nerve, moderate to severe loss of visual acuity, and abnormalities of
color vision [25,26].
2.3. DRP1
DRP1 is a key regulator of mitochondrial ﬁssion that is recruited to
ﬁssion sites alongmitochondria and is actively involved in the scission
process. Recruitment of DRP1 to mitochondria is regulated by several
post-translational modiﬁcations such as phosphorylation and sumoy-
lation [27]. DRP1 plays an essential role in several aspects of
mitochondrial function. For example, in neurons, DRP1-mediated
ﬁssion allows distribution of mitochondria along dendrites and is
essential for synapse development [8,28,29].3. Mitochondrial dynamics and cell death
As outlined above, mitochondria play a vital role in cellular
homeostasis, while regulation of their dynamics is central to proper
mitochondrial function. Paradoxically, mitochondria also play a key
role in the regulation of cell death, and mitochondrial dynamics
constitutes an integral part of the pathways leading to the demise of
the cell. In the central nervous system, two major types of cell death
occur following acute injury, apoptosis and excitotoxicity, both of
which are sensitive to themodulation of the ﬁssion/fusionmachinery.
3.1. Classical apoptotic cell death
Classical apoptotic cell death is a tightly regulated process
controlled by members of the BCL-2 family of proteins. Induction of
apoptosis by intracellular signals such as DNA damage or ER stress
leads to the activation of the pro-apoptotic BCL-2 homologues BAX
and BAK, which promote cytochrome c release from mitochondria
and subsequent activation of caspases, the apoptotic proteases.
Apoptosis plays an important role in injury-induced neuronal death.
Indeed, biochemical hallmarks of apoptosis have been observed in
cells following both focal and global ischemia [30,31] while animals
overexpressing BCL-2 are more resistant to stroke [32,33]. One
important apoptotic trigger following neuronal injury is the reactive
oxygen species (ROS) that are generated during hypoxia/reperfusion.
ROS cause DNA damage, leading to p53-dependent activation of
apoptosis [34–36].
Multiple studies have substantiated a link between mitochondrial
dynamics and the classical apoptotic pathway. For example, in
neuronal cells, mitochondria undergo excessive ﬁssion in response
to ROS, DNA damage, and NO, which can be prevented by the
expression of MFN2 or a dominant-negative form of DRP1 (K38A)
[14,37]. Dominant-negative DRP1 also rescued cell survival under
these conditions, indicating that Drp1-mediatedmitochondrial ﬁssion
is an early event contributing to the collapse of mitochondria and cell
death. Similarly, loss of MFN1, MFN2, or OPA1 leads to mitochondrial
fragmentation and increased sensitivity to cell death stimuli
[20,38,39], while overexpression of these proteins leads to better
survival in several cell types including neurons [14,37]. Importantly,
in the absence of injury, loss of MFN2 results in neuronal loss in vitro
[14] and degeneration of Purkinje neurons in vivo [40], highlighting
the importance of mitochondrial fusion proteins in neuronal survival.
At the molecular level, two potentially overlapping mechanisms
have been proposed to explain the importance of ﬁssion during
apoptosis. First, apoptotic DRP1-dependent mitochondrial fragmen-
tation is associated with opening of the cristae structure and
mobilization of cytochrome c, which can then be rapidly released
upon OMM permeabilization [41,42]. Consequently, interfering with
mitochondrial ﬁssion using a dominant-negative DRP1 prevents the
reorganization of the cristae, dampening cytochrome c release and
caspase activation [41]. Second, several components of the ﬁssion/
fusion machinery have been associated with the regulation of BAX/
BAK activation. For example, DRP1 and MFN2 have been found in
puncti with BAX and BAK [43]. In addition, overexpression of MFN2 or
the MFN2RasG12V mutant inhibits BAX activation and protects against
cytochrome c release in cell lines and primary neurons [13,14]. MFN2
has also been suggested to interact with the anti-apoptotic BCL-2
homologue BCL-XL and its C elegans homologue CED9 [44], although
the signiﬁcance of this interaction for cell survival has not been
addressed. Other proteins involved in mitochondrial fusion/ﬁssion
also interact with BAX. For example, Endophilin B1 (Bif-1, SH3GLB1),
a protein of the endophilin family that plays a role in membrane
dynamics, has been shown to regulate both mitochondrial dynamics
and activation of BAX [45,46].
Interestingly, the cross-talk between mitochondrial dynamics and
BCL-2 homologues seems to go both ways. Indeed, BCL-XL was shown
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biomass, leading to increased synapse formation in cultured primary
neuron [44,47,48]. Similarly, deﬁciency of both BAX and BAK in the
BAX/BAK double knockout (DKO) cells caused fragmentation of the
mitochondrial network. This defect was mapped to alterations in the
regulation of MFN2 [49], as BAX promoted the recruitment of MFN2
into foci associated with ﬁssion/fusion sites. Of note, a constitutively
active, GTP-bound form of Mfn2 (MFN2RasG12V) reinstated fusion in
MFN2 knockout but not DKO cells where it also failed to redistribute
to ﬁssion/fusion foci [49]. Similar clusters containing BAX/BAK,
MFN2, and DRP1 have previously been described in apoptotic cells
and associated with the cytochrome c release activity of BAX. It is
therefore possible that the enhanced anti-apoptotic activity of
MFN2RasG12V relates to its inability to be recruited to the apoptotic
BAX foci, which could interfere with the activation of BAX within
these foci. However, this remains to be tested, as other models of BAX
activation suggest that BAX-induced cytochrome c release is driven
by much smaller BAX oligomers that directly permeabilize the OMM
[50–52].
3.2. Excitotoxic cell death
Apoptosis is an important mode of cell death in most mammalian
tissue during development and in the context of cellular damage.
However, a second mode of cell death, excitotoxicity, is a major cause
of neuronal loss following acute brain injury. Excitotoxicity is caused
by an excessive synaptic release of the neurotransmitter glutamate,
causing the overactivation of glutamate receptors. Several down-
stream pathways then lead to a BAX/BAK-independent form of cell
death with characteristics of both apoptosis and necrosis (reviewed in
[53,54]). For example, activation of NO synthase by PSD95 down-
stream of the NMDA receptor leads to the generation of highly
reactive peroxynitrites, causing cellular damage and cell death.
Excessive calcium inﬂux following NMDAR overactivation also
activates several potentially deleterious signaling cascades. A major
effect of calcium overload is the alteration of mitochondrial function.
Mitochondria act as a calcium buffer following calcium release from
the endoplasmic reticulum or through cell surface receptors [55] but
also respond to calcium inﬂux by increasing their metabolism [56].
However, if mitochondrial calcium increases over a certain value, a
channel freely permeable to water and ions, the permeability
transition pore (PTP), is open [57]. Opening of the PTP causes swelling
and rupture of the OMM in a process that is completely distinct from
BAX/BAK-dependent OMM permeabilization. This leads to the
disruption of energy production and release of cytotoxic factors,
such as apoptosis-inducing factor (AIF) and EndoG, from mitochon-
dria. These factors then converge on the nucleus, causing DNA
fragmentation and cell death. In addition, calcium-dependent activa-
tion of μ-calpain promotes the release of AIF from mitochondria
[58,59]. Calcium overload-induced mitochondria dysfunction also
leads to the formation of ROS, causing further cellular damage.
As with apoptosis, components of the ﬁssion/fusion machinery
inﬂuence excitotoxic cell death. For example, NO-induced toxicity in
primary cortical neurones involves mitochondrial fragmentation and
is prevented by overexpression of MFN1 or dominant-negative DRP-1
[37]. Similarly, overexpression of MFN2 or OPA1 protected neurons
from NMDA-induced cell death (Jahani-Asl et al, submitted for
publication). However, neither downregulation of DRP1 or over-
expression of MFN1 rescued NMDAR overactivation-induced toxicity
[37], suggesting that mitochondrial fusion alone might not be
sufﬁcient and that other pathways, such as calcium handling by
mitochondria, might be involved.
Links between calcium and mitochondrial structure and function
arewell documented. For example, sustained calcium release from the
ER cause DRP1-dependent mitochondrial fragmentation [60], while
Miro, a mitochondrial protein containing an EF-hand calcium bindingdomain, regulates mitochondrial transport in a calcium-dependent
manner. Interestingly, MFN2 has recently been shown to tether
mitochondria and ER, affecting ER calcium content [17]. The close
association between ER and mitochondria is indeed thought to be
critical for calcium handling. A possible link between mitochondrial
calcium and OPA1 activity was also recently highlighted by the
observation that LETM1, a mitochondrial EF-hand-containing protein,
affects OPA1 processing and mitochondrial structure [61]. Calcium-
induced modulation of OPA1 activity could potentially help preserve
mitochondrial structure at higher calcium load by maintaining cristae
structure.
In addition to the inﬂuence of the core ﬁssion/fusion machinery,
mitochondrial movements play an important role in calcium
handling. Mitochondria are transported in an anterograde fashion
along microtubules by the motor protein Kinesin-1, which binds to
mitochondria through an adaptor complex formed of Miro andMilton
[62,63]. In the presence of high calcium levels, Kinesin-1 is dissociated
from microtubules through the action of calcium-bound Miro,
concentrating mitochondria at sites of high calcium concentration.
This serves two purposes: it allows increased buffering of calcium by
mitochondria and also increases local ATP production to help pump
calcium out of the cell. The signiﬁcance of this was highlighted by the
observation that a Miro mutant that did not respond to calcium
increased NMDA toxicity. Overexpression of Miro can also increase
mitochondrial length, which could further help buffering calcium
[63]. However, as mitochondrial ﬁssion is required for proper
distribution of mitochondria to synaptic terminals, the balance
between ﬁssion, fusion, and mitochondrial movements rather than
activation of one or the other is likely to be the critical readout. This is
exempliﬁed by the mitochondrial phenotype in Alzheimer's disease
neurons, where both ﬁssion and fusion proteins are affected, resulting
in a reduced axonal distribution of mitochondria [64]. In that context,
expression of DRP1 improved synaptic function following amyloid-β
treatment by promoting the redistribution of mitochondria to
synapses.
3.3. Concluding remarks
In summary, a strong link has been uncovered in recent years
between cell death and mitochondrial dynamics. Several questions
remain however, especially with regards to excitotoxicity where the
interplay between ﬁssion/fusion and mitochondrial movements is
likely to play a critical role. For example, it still remains to be
determined whether fusion per se is protective, or if other
cytoprotective roles of fusion proteins (such as signaling functions)
are the dominant factor. The balance between ﬁssion and fusion also
needs to be taken in account, as ﬁssion is required to distribute
mitochondria to their proper location within the cell. Given these
caveats, modulation of these pathways will likely have far-reaching
consequences beyond the regulation of calcium signaling described
here, but that warrant further research.
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